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be explained by the low TC levels found in the study
sample, but could also be a result of a lack of knowledge
about hypercholesterolaemia.
Our study population had low TC, LDLC and favourable
HDLCfTC ratios, all protective against CHD, which may
partially explain the relatively low prevalence of CHD. There
were, however, individuals who exceeded the recommended
lipid cut-off levels for CHD risk. This, combined with the fact
that the population as a whole had a lipid profile showing
signs of a possible change towards that of a typical urban
population, should be a warning that changes are occurring
and that preventive measures should be considered. Suffice
to say that our study indicated a transition from a rural
toward an urban lipid profile.
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C. A. Gudgeon, I. D. Werner, D. M. Dent
Objective. To determine the accuracy and cost-
effectiveness of skeletal scintigraphy in women with early,
node-negative (T1-2NOMc) breast cancer.
Design. Retrospective, where scintigraphic prediction of
metastases was compared with the criterion standard of
radiological confirmation during a follow-up of 5 - 10 years.
Setting. Tertiary referral breast clinic at Groote Schuur
Hospital.
Patients. Six hundred and seventy-three women with
clinical Tl.2~Mo breast cancer who had skeletal
scintigraphy between 1974 and 1987, and who had been
followed up for more than 5 years.
Interventions. Initial skeletal scintigraphy, annual follow-
up with radiological examination of symptomatic areas.
Main outcome measures. Correlation of the sites
indicated by scintigraphy with the inrtial presence or later
development of metastases at 1 - 10 years, and the cost.
Results. Five hundred and sixty-one (83.4%) scans were
normal, 35 (5.2%) indicated benign processes, and 77
(11.4%) were suggestive or diagnostic of metastatic
disease, with radiological confirmation in 3 (inrtial
detection rate 3/673, 0.44%; accuracy rate 3m, 3.9%). Of
the remaining 74 abnormal scans without radiological
confirmation of metastases, 62 had a focus at a single
srte, and 45 were of low intensity and equiVOCal, with no
apparent explanation. The cumulative sensitivity for
predicting site of metastases at 1 year was 33% (3/9) and
the positive predictive value 4.0% (3/75). At 10 years the
sensitivity was 5.0% (3/60) and the positive predictive
value 5.0% (3/65). The total cost of screening was
calcula1ed to be R323 460.00, suggesting that the cost
for each patient in whom metastases were detected was
R64 629.00.
Conclusion. While scintigraphy may be of value in
symptomatic or more advanced disease, screening of
node-negative women had a minimal detection rate, was
expensive and cannot be supported.
S Af, Med J 1996; 86: 166-169.
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Breast cancer is a leading cause of death in women
worldwide. Successful management of the disease requires
accurate staging, estimation of prognosis and selection of
therapy appropriate for stage. Therefore, a detailed
knowledge of the extent of the loco-regional disease is
necessary together with information whether distant
metastases are present or not. The major sites of metastatic
spread are the skeleton, lungs, pleura and liver. Skeletal
scintigraphy remains the most common screening test for
asymptomatic skeletal metastases, and its superiority over
radiography is well established. 1 Despite this, after having
enjoyed initial enthusiasm and support as a baseline
screen,2.... scintigraphy has subsequently been criticised for
having a low rate of detection.5-7 Nonetheless, the test
remains in use in many academic units, and is used with
increasing frequency in the private sector.
The cost of skeletal scintigraphy is rising each year and
the cost-effectiveness of using such a test in women with
apparently early breast cancer is an important factor for
evaluation. This study was therefore designed to determine
the sensitiVity and specificity of skeletal scintigraphy for the
detection and prediction of metastatic disease in women




to the spine unless otherwise indicated; between 1980 and
1987 patients were scanned with a whole-body Elscint
gamma camera that gave anterior and posterior whole-body
views. The isotope technetium-99 m ~Tc) medronate was
used in doses of 740 M Bq (20 mei) and the scans were
interpreted by the Department of Nuclear Medicine. The
diagnostic outcome of the bone scan was evaluated as
normal, benign (radiological evidence of a benign lesion),
suspicious of metastatic disease (asymmetrical uptake with
normal radiographs) or metastatic disease when there was·
radiological confirmation of this.
Calculations
Possibilities of outcome were analysed on a conventional
decision tree. Costs were calculated in South African rands
using the 1991 tariffs of the MASA' (skeletal scintigraphy
R411, radiograph R83, hospital visit R55). MASA tariffs were
used as they were felt to be economically more reliable than
state-subsidised hospital tariffs. Hidden expenditure such as
staff training, equipment maintenance and the use of raw
materials are then directly included in the assessment.
Results
Table J. Initial skeletal scintigraphic result with radiological
diagnoses
The scans were normal in 561 (83.4%) patients, various
benign conditions were reported in 35 (5.2%), and
metastatic disease suggested in 77 (11.4%) (Table I). There
was radiological confirmation of metastases in 3 patients, all
of whom had lesions at multiple sites, particularly in the
skull, ribs, pelvis and spine. The radiologicaJly confirmed
detection rate was therefore 0.44% (3/673) and the accuracy
rate was 3.9% (3177). In 74 patients the scans were
abnormal, but lacked radiological confirmation of
metastases. The majority of these scans had a focus at a
single site, and in 45 instances the focus was of low
intensity and equivocal (fable 11). There was no explanation
for the abnormal scans.
Patients and methods
Patient selection
We retrospectively examined the records of 1 168 female
patients with histologically proven breast cancer who had
been clinically staged as having T1-2NaMa disease. :These
women had presented to the Groote Schuur Hospital breast
clinic between January 1974 and December 1987. We
excluded 165 as their records were incomplete. Out of the
remaining 1 003, skeletal scintigraphy was performed in 673
patients, who constiMed this study group. Skeletal
scintigraphy had not been performed in certain patients for
the following reasons: 131 were older than 65 years (the
policy of the clinic was not to perfonn scans in patients older
than 65 years as osteo-arthritis and similar conditions are
common in this age group and may give rise to false-positive
resulls); 133 were assessed between 1974 and 1978 when
scanning was not performed routinely; 48 patients had
skeletal scintiscan taken by a private radiologist before
attending and 18 patients declined the investigation.
Skeletal scintigraphy
The skeietal scintiscans were taken pre-operatively and the
resu~s evaluated before surgery. Between 1974 and 1979, a























Table 11. Subsequent development of metastases over 10 years in the three groups of patients whose scans were reported as normal,
suggestive of benign disease or suggestive of skeletal metastases
Years
0 2 3 4 5 6 7 8 9 10 Total (%)
Normal 561 4 11 12 8 4 4 5 3 1 2 54 (9.6)
Benign 35 1 2 3 (8.6)
Metastatic n 2 1 4 2 2 12 (16.2)
- - -
Total 673 6 13 16 12 4 4 6 3 3 2 69 (8.l)
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Discussion
We found the detection rate of skeletal metastases by
skeletal scintigraphy to be negligible in women with
apparent node-negative breast cancer. This has also been
the experience of others.1•1I•10 This is partly to be expected, as
such women have a true low incidence of metastases, the
likelihood of their development being 20% at 10 years."
Therefore, even if scintigraphic screening had an absolute
sensitiVity and specificity for metastases, the frequency of a
positive test would be low in any event. We feel that it is
unlikely that among those patients excluded because of
incomplete records, there could have been some who were
scanned and who had metastases detected. No one has
been able to confirm Galasko's initial 1974 reporF of a 24%
detection rate of metastatic bone disease in early breast
cancer. The Danish Breast Cancer Co-Operative Group12 an~d
the Scottish Breast Groupl] found higher detection rates
than ours - of the order of 5% - but their analyses
included stage 2 and operable stage 3 disease. The data
from this study have shown not only a low detection rate
(sensitiVity) for metastatic disease but also a moderate
specificity and a very low positive predictive value. Only 3
patients obtained direct diagnostic benefit from the initial
screening tests and were spared inappropriate surgery or
radiotherapy.
The low specificity and high false-positive diagnostic rate
of skeletal scintigraphy present a serious clinical problem.
Where there is radiological support for the diagnosis of
metastases, appropriate therapeutic decisions may be
taken. It is clear, however, that on occasion true metastases
may be detected scintigraphically, but be radiologically
confirmed. The clinician is therefore faced with the dilemma
of regarding a scintigraphic abnormality either as occult
metastatic disease (Without radiological evidence) or as
falsely positive. The latter would seem to be the wise
conclusion in the context of screening for metastases in
nOde-negative women.1
Constraints are being placed on hospital and medical aid
expenditure worldwide. There has been a focus on
appropriate and cost-effective spending of limited resources
and, in this context, tests that provide results that cause
negligible treatment changes are of questionable value.'•
While we have undertaken a simple costing exercise that
used only three components, we feel that it does make a
strong point, and may even underestimate the cost. The high
cost of scintigraphy, when calculated for the number of
patients in whom metastases were detected, has been
pointed out by others.I] Metastatic screening using skeletal
scintigraphy. therefore has a very low yield in women with
node-negatiVe breast cancer, is very expensive, may
adversely affect quality of life and cannot be justified. This
does not minimise the value of scintigraphy in more





In addition to the initial 3 patients who had metastases
correctly identified by scintigraphy, a further 6 women
developed skeletal metastases after 1 year (fable Ill), having
presented with localised pain and having had metastases
confirmed by radiography of the area concerned. Four of
these had previously had normal scintiscans and 2 had had
scintiscans that had reported metastatic disease (but
without radiological confirmation of it). In both the latter
patients, the bone metastases developed at different sites
(right acetabulum, dorsal spine) from the suspicious areas
initially reported (left greater trochanter, lumbar spine). Thus
at 1 year the test had a cumulative sensitivity of 33% (319), a
specificity of 89% (592/664) and a positive predictive value
of 4.0% (3/75).
Sixty-nine women had developed skeletal metastases by
10 years. Fifty-four of them had had normal scintiscans
previously. In a further 3 patients both the scintiscans and
radiographs had confirmed benign lesions, and in each case
the metastases developed away from that site. Twelve
patients had an initial scintiscan that had shown metastatic
disease, but without radiological evidence of disease at that
time. In 3 instances metastases developed in those areas
that were regarded as scintigraphically suspicious. However,
in each of these 3 cases there was a diffuse distribution of
metastases and the previous localised report of abnormality
may have been a coincidence and not a predictive factor.
The metastases developed at 2, 3, and 4 years respectively
after the initial scintigraphic report of metastatic lesions.
Therefore, at 10 years the sensitivity was 5.0% (3160), the
specificity 90.0% (539/601) and the positive predictive value
4.6% (3/65).
A decision tree analysis (Fig. 1) demonstrated that the
most common pathway was a normal scan and for no
metastases to develop within the first year (probability
0.827). Less common pathways were for the development of
metastases with a normal scan (4 patients, probability
0.006), and with an abnormal scan (5 patients, probability
0.16). The total cost of reassurance (path I) was
R259 562.00, the cost of missing metastases (path 2) was
R2 196.00, the cost of concern (path 3) was R58 743.00.
The apparent cost of detecting metastases (path 4) was
R2 745.00. Overall, the real cost was R64 692.00 per patient
in whom metastases were detected.
Fig. 1. Decision tree calculating outcome probabilities of bone
scan results.
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Evidence of undue lead
exposure in Cape Town
before the advent of leaded
petrol
s. R. Grobler, F. S. Theunissen, L. S. Maresky
Lead concentrations were determined in the exhumed
teeth of 28 people who lived in the Cape Town area before
the combustion of leaded petrol ~.e. before 1922). The
lead content of circumpulpaJ dentine was analysed by
graphite-furnace atomic absorption spectromeby. The
mean lead level in the dentine of primary teeth (N = 6) was
109 ~glg, while that in secondary teeth (N = 22) was
315 ~g/g. The current lead levels in circumpulpal dentine
of Cape Town residents are reported to be 7~ ~glg and
16 ~glg for primary and secondary teeth respectively.
It was found that lead pollution of the human body during
the period 1812 - 1922 in the Cape Town area was
substantially higher than at present. We conclude that the
main reasons for this were the widespread use of lead
piping and soldering of water tanks, which resulted in a
higher incidence of lead poisoning than that attributable to
leaded petrol.
S Afr Med J 1996; 86: 169-171.
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Lead has no metabolic role in the human body and its
presence is associated with various toxic effects. ' -3 The
deposition of lead in calcified tooth structure is indelible
evidence of exposure to and absorption of lead. Under
normal circumstances there is no turnover of calcified tooth
structure once its matrix is complete and mineralised. In man,
this absence of tissue turnover is unique to the calcified tooth
layers.~ Therefore, tooth biopsies in vivo or after the removal
of teeth from the body provide an absolutely reliable source
of information about the deposition therein of substances
such as lead, fluoride and tetracycline. Furthermore, the age
at which the deposition took place can also be determined
with a high degree of accuracy.
The deposition of lead in tooth structure is mainly the result
of circulating blood lead. which is acquired largely via the
inhalation of lead aerosol and. to a lesser extent, gastro-
intestinal absorption.' Blood lead levels may fluctuate,
dependent upon exposure to external sources and limited
remobilisation of lead in bone and soft tissue during turnover.
The presence of lead in different tissues of various South
African populations has been studied since the early
1980s.5.12 However, the exhumation of human remains
necessitated by urban redevelopment in the Cape Town
area afforded a unique opportunity to determine lead
concentrations in calcified tooth structures of people who
lived in the Cape Town area during the period 1810 - 1922.
Prior to 1921, minimal combustion of petrol took place in
South Africa. Furthermore, leaded fuel was not utilised
during that time. However, prior to 1922 the popUlation was
exposed to lead contamination in water reticulation systems.
ceramic utensils, pewterware and minimal amounts of
industrial and occupational waste. From 1922, an ever-
increasing number of vehicles dependent upon leaded petrol
for their fuel combustion came into use in South Africa.
The object of this study was to determine the lead
concentrations in the circumpulpal dentine of the teeth of a
population group who lived in the Cape Town area in the
period before the combustion of leaded petroleum.
Materials and methods
The teeth of 28 people, buried between 1863 and 1922 and
exhumed recently, were analysed. The circumpulpal dentine
was separated mechanically from tile rest of each tooth with
the help of a diamond disc cutter. t3 The collected pieces of
dentine of each tooth were etched with 1.0M hydrochloric
acid to remove contarnination:washed with lead-free water,
dried, weighed' and ashed in nitric acid as described by
Keating et al. I~ The lead in the final solution, which contained
5% nitric acid, was determined by means of graphite-
furnace atomic absorption spectrometry, basically according
to the method of Keating et al. "
Results
The average age of the subjects was 43.6 years (SO = 29.3;
median = 53.5; range 0.5 - 89 years). Table I shows the
circumpulpal lead concentration (~glg) in the exhumed teeth.
The influence of age at the date of death on the lead levels
is summarised in Table 11. In general the lead concentration
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